Draagon Drugs to expand its drug unit at Jhagadia in Bharuch district of Gujarat with an investment of Rs. 10.0 million.
Details of products and their production capacities are given below:
Sr. No. | Product | Present capacity (Mt/Month) | Proposed capacity (Mt/Month) | Total capacity (Mt/Month) |
| Metanilic acid | 240 | --- | 240 |
| Benzidine 22 Di Sulphonic acid | ---- | 500 (Either individual or total of all 9 products will be manufactured) | 500 (Either individual or total of all 9 products will be manufactured) |
| 3,5 Di Amino Benzoic acid | |||
| Para Cumidine | |||
| Para Toludine | |||
| OrthoToludine | |||
| Ortho Cumidine | |||
| Para Anisidine | |||
| Ortho Anisidine | |||
| Meta Anisidine | |||
By products | ||||
| Di Nitro Di Phenyl Sulphone | 6 | 12.5 | 18.5 |
| Sodium Salt Solution | --- | 690 | 690 |
Micron Pharmaceuticals to set up bulk drug unit at Vapi in Valsad district of Gujarat with an investment of Rs. 100 million. Details of products along with their production capacities are given below:
Sr. No. | Product | Total Capacity (MTPM) |
1 | Quinine Sulphate | 10
|
2 | Quinine Bisulphate | |
3 | Quinine Hydrochloride | |
4 | Quinine Dihydrochloride | |
5 | Fentanyl Citrate | |
6 | Danazol | |
7 | Succinyl Choline Chloride | |
8 | Capacitabine | |
9 | Fenofibrate | |
10 | Tazobactam Sodium | |
11 | Gemcitabin Hydrochloride | |
12 | Bacampicillin Hydrochloride | |
13 | Cefoxitin Sodium | |
14 | Artesunate | |
15 | Artemether | |
16 | Apomorphine Hydrochloride | |
17 | Sildenafil Citrate | |
18 | Fluticasone Propionate | |
19 | Cyclopentolate Hydrochloride | |
20 | Dihydro Artemisinin | |
21 | Eflornithine Hydrochloride Monohydrate | |
22 | Cefixime | |
23 | Triprolidine Hydrochloride | |
24 | Sodium Stearyl fumarate | |
25 | Piperacillin Sodium | |
26 | Methadone Hydrochloride | |
27 | Buprenorphine Hydrochloride | |
28 | Amifostine | |
29 | Cefuroxime Axetil | |
30 | Arteether | |
31 | Ceftiofur Sodium | |
32 | Ceftiofur Hydrochloride | |
33 | Erythromycin Stearate |
*The unit will either manufacture any one product out of thirty-three products with total qty not exceeding 10 MT/Month or cumulative qty of thirty-three products not exceeding 10 MT/Month.
R P industries to expand its pharma base intermediates unit at Panoli in Bharuch district in Gujarat with an investment of Rs. 3.0 million . The production capacity will be enhanced from 25 MTPM to 63.2 MTPM. About 30.97 MTPM of Sodium Sulfide will be manufactured as byproduct. The proposed expansion will be carried with in the existing unit having land area of 3780 m2.
Details of products and their production capacities are given below:
Sr. No. |
Name of Product | Existing (MTPM) | Proposed (MTPM) | Total (MTPM) |
01 | 5, Methoxy, Mercapto Benzimidazol | 10.0 | 20.0 | 30.0 |
02 | 2 Mercapto Benzimidazol | 05.0 | --- | 05.0 |
03 | 5, Methyl 2 Mercapto Benzimidazol | 10.0 | 10.0 | 20.0 |
04 | Ethyl Methylamine 40% in toluene. | --- | 01.0 | 01.0 |
05 | Di Phenyl Carbamyl Chloride | --- | 00.5 | 00.5 |
06 | Iso Propyl Iso Cynate 75% in Toluene | --- | 00.2 | 00.2 |
07 | Acetone Thiosemicarbazone | --- | 06.5 | 06.5 |
Total | 25.0 | 38.2 | 63.2 |
Sr. | Name of By Product | Quantity ( MTPM) |
1 | Sodium Sulfide | 30.97 |
Bakul Pharma to expand its bulk drug unit at Ankleshwar in Bharuch in Gujarat with an investment of Rs. 0.6 million. The production capacity will increased from 31.5 MTPM to 34.6 MTPM.
Details of products along with their production capacity are given below:
PRODUCT NAME
| CAPACITY (MTPM)
| ||
EXISTING | PROPOSED | TOTAL | |
PRODUCTS | |||
Theobromine BP/EP | 10 | - | 10 |
Doxophylline (DOX) | - | 2 | 2 |
DRZ V | - | 1 | 1 |
GCV VI | - | 0.1 | 0.1 |
BY PRODUCT | |||
Caffeine IP/BP | 1.5 | - | 1.5 |
Acetic Acid | 20 | - | 20 |
TOTAL | 31.5 | 3.1 | 34.6 |
11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy